Shigellosis is a major enteric disease worldwide causing diarrhea and dysentery, an acute invasive disease of the lower intestines in many parts of the world with a very low infectious dose (approximately 100 bacteria). Because of the multiple-antibiotic resistance of many strains of Shigellae, the treatment of shigellosis is difficult and prevention by vaccination should be an alternative to control this disease. We hypothesized that extended fragments of the O-specific polysaccharide (O-SP) components of the lipopolysaccharides of Shigellae may be suitable for the induction of protective antibodies when covalently coupled to immunogenic proteins. The use of synthetic saccharides of defined structure instead of polysaccharides of highly complex architecture offers numerous advantages including enhanced uniformity of conjugates, the possibility of using saccharides with pre-determined termini on the saccharide chain, and elimination of much of the analytical difficulties associated with the polysaccharide-protein vaccines. In addition, the possible dangers inherent with materials of biological origin are also minimized. Based on this hypothesis we are developing synthetic oligosaccharide-based immunogens of well-defined molecular characteristics. We designed a synthetic strategy to prepare oligosaccharide fragments of the O-SP of S. dysenteriae type 1. The O-SP consists of a tetrasaccharide repeating unit that is composed of D-galactose, N-acetyl-D-glucosamine, and L-rhamnose. Starting from monosaccharides that carry orthogonal protecting and activating groups, a tetrasaccharide donor/acceptor molecule was assembled. Iterative combination of the building blocks afforded di-, tri- and tetramers of the repeating unit corresponding to octa-, dodeca- and hexadeca-saccharide portions of the native O-SP. These oligo/polysaccharides are equipped with an w-hydrazinocarbonylpentyl aglycon that can be used to anchor the saccharides to proteins and other macromolecules. A new heterobifunctional linker molecule was developed and used to attach the saccharides to proteins under mild conditions.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Intramural Research (Z01)
Project #
1Z01HD001313-03
Application #
6162486
Study Section
Special Emphasis Panel (LDMI)
Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1997
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Kubler-Kielb, Joanna; Vinogradov, Evgeny; Ben-Menachem, Gil et al. (2008) Saccharide/protein conjugate vaccines for Bordetella species: preparation of saccharide, development of new conjugation procedures, and physico-chemical and immunological characterization of the conjugates. Vaccine 26:3587-93
Pozsgay, Vince (2008) Recent developments in synthetic oligosaccharide-based bacterial vaccines. Curr Top Med Chem 8:126-40
Pozsgay, Vince; Kubler-Kielb, Joanna (2007) Synthesis of an experimental glycolipoprotein vaccine against Lyme disease. Carbohydr Res 342:621-6
Robbins, John B; Schneerson, Rachel; Keith, Jerry M et al. (2007) The rise in pertussis cases urges replacement of chemically-inactivated with genetically-inactivated toxoid for DTP. Vaccine 25:2811-6
Pozsgay, Vince; Kubler-Kielb, Joanna; Schneerson, Rachel et al. (2007) Effect of the nonreducing end of Shigella dysenteriae type 1 O-specific oligosaccharides on their immunogenicity as conjugates in mice. Proc Natl Acad Sci U S A 104:14478-82
Pozsgay, Vince; Ekborg, Goran; Sampathkumar, Srinivasa-Gopalan (2006) Synthesis of hexa- to tridecasaccharides related to Shigella dysenteriae type 1 for incorporation in experimental vaccines. Carbohydr Res 341:1408-27
(2006) A new method for conjugation of carbohydrates to proteins using an aminooxy-thiol heterobifunctional linker. J Org Chem 71:5422
Fekete, Aniko; Hoogerhout, Peter; Zomer, Gijsbert et al. (2006) Synthesis of octa- and dodecamers of D-ribitol-1-phosphate and their protein conjugates. Carbohydr Res 341:2037-48
Kubler-Kielb, Joanna; Pozsgay, Vince (2005) A new method for conjugation of carbohydrates to proteins using an aminooxy-thiol heterobifunctional linker. J Org Chem 70:6987-90
Pozsgay, V (2000) Oligosaccharide-protein conjugates as vaccine candidates against bacteria. Adv Carbohydr Chem Biochem 56:153-99

Showing the most recent 10 out of 14 publications